CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-13 | Patrick Todd Director | Grant or award · Stock Options (Right to Buy) | +33,000 | 33,000 | ||
| 2021-03-25 | Patrick Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2020-12-08 | Patrick Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2019-05-22 | Patrick Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +298,724 | 298,724 |
Page 1 of 1 · 4 trades